A Phase II Study of Single Agent Gemcitabine In Relapsed or Refractory Follicular or Small Lymphocytic Non-Hodgkin’s Lymphoma

Manuscripts/Articles:

• Kristen N Ganjoo, William Fisher, John McClean, Sang Yoon Huh, Jose Bufill, Sheron Williams,and Larry D Cripe. A Phase II Study of Single Agent Gemcitabine in Relapsed or Refractory Follicular or Small Lymphocytic non-Hodgkin’s Lymphomas: A Hoosier Oncology Group Study NHL00-1. Am J Clin Oncol 2005; 2 (28): 169-72